Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.65 |
| ▸ | MEN1 | O00255 | 12/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 12/20 | 0.64 |
| ▸ | MYC | P01106 | 5/20 | 0.64 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | GSTM2 | P28161 | 2/20 | 0.57 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.57 |
| ▸ | MAX | P61244 | 1/20 | 0.57 |
| ▸ | MIF | P14174 | 1/20 | 0.56 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8788690 | 0.85 | MEN1 (0.66) | IDO1MEN1KMT2AMYCPOLB | |
| SCHEMBL7052057 | 0.84 | GSTM2 (0.66) | IDO1MEN1KMT2AMYCPOLB | |
| SCHEMBL593192 | 0.83 | MEN1 (0.64) | IDO1MEN1KMT2AMYCPOLB | |
| SCHEMBL9099360 | 0.83 | MEN1 (0.64) | IDO1MEN1KMT2AMYCPOLB | |
| SCHEMBL27934659 | 0.83 | MEN1 (0.64) | IDO1MEN1KMT2AMYCPOLB | |
| SCHEMBL7904806 | 0.83 | MEN1 (0.64) | IDO1MEN1KMT2AMYCPOLB | |
| SCHEMBL8788859 | 0.83 | IDO1 (0.60) | IDO1MEN1KMT2AMYCPOLB | |
| SCHEMBL17781757 | 0.83 | MEN1 (0.67) | IDO1MEN1KMT2AMYCPOLB | |
| SCHEMBL12337785 | 0.83 | IDO1 (0.60) | IDO1MEN1KMT2AMYCPOLB | |
| SCHEMBL19222011 | 0.82 | GSTM2 (0.67) | IDO1MEN1KMT2AMYCPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100184601-A1 | Method and Means Relating to Multiple Herbicide Resistance in Plants | UNIVERSITY OF DURHAM (GB) | 2010-07-22 | — | — | US | claimed |
| EP-2190290-A2 | METHOD AND MEANS RELATING TO MULTIPLE HERBICIDE RESISTANCE IN PLANTS | University Of Durham (GB) | 2010-06-02 | — | — | EP | claimed |
| WO-2009034396-A2 | METHOD AND MEANS RELATING TO MULTIPLE HERBICIDE RESISTANCE IN PLANTS | UNIVERSITY OF DURHAM (GB) | 2009-03-19 | — | — | WO | claimed |
| US-20230173018-A1 | CASPOFUNGIN DERIVATIVES AND ASSAYS FOR EVALUATING ANTIFUNGAL TREATMENT EFFICACY | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2023-06-08 | — | — | US | disclosed |
| US-10967096-B2 | Tissue sealant compositions, vascular closure devices, and uses thereof | MEDIBEACON INC. (US) | 2021-04-06 | — | — | US | disclosed |
| US-10960104-B2 | Tissue sealant compositions, vascular closure devices, and uses thereof | MEDIBEACON INC. (US) | 2021-03-30 | — | — | US | disclosed |
| US-10881759-B2 | Tissue sealant compositions, vascular closure devices, and uses thereof | MEDIBEACON INC. (US) | 2021-01-05 | — | — | US | disclosed |
| US-20190192727-A1 | TISSUE SEALANT COMPOSITIONS, VASCULAR CLOSURE DEVICES, AND USES THEREOF | MALLINCKRODT INC. | 2019-06-27 | — | — | US | disclosed |
| US-20190192728-A1 | TISSUE SEALANT COMPOSITIONS, VASCULAR CLOSURE DEVICES, AND USES THEREOF | MALLINCKRODT INC. | 2019-06-27 | — | — | US | disclosed |
| US-20180120314-A1 | FLUORESCENT POLYBRANCHED PROBES FOR DETECTING BACTERIA AND/OR FUNGI IN VITRO AND IN VIVO | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2018-05-03 | — | — | US | disclosed |
| US-20160331862-A1 | TISSUE SEALANT COMPOSITIONS, VASCULAR CLOSURE DEVICES, AND USES THEREOF | MALLINCKRODT INC. | 2016-11-17 | — | — | US | disclosed |
| US-20080262254-A1 | Sphingolipids | ETTMAYER PETER | 2008-10-23 | — | — | US | disclosed |
| US-20080075660-A1 | Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications | CELLECTAR, LLC (US) | 2008-03-27 | — | — | US | disclosed |
| US-20080014649-A1 | Method for the Determination of Body Odor | KAO CORPORATION (JP) | 2008-01-17 | — | — | US | disclosed |
| US-20080014649-A1 | Method for the Determination of Body Odor | KAO CORPORATION (JP) | 2008-01-17 | — | — | US | disclosed |
| US-7297495-B2 | Hybridization-triggered fluorescent detection of nucleic acids | EPOCH BIOSCIENCES, INC. (US) | 2007-11-20 | — | — | US | disclosed |
| US-20070166723-A1 | Hybridization-triggered fluorescent detection of nucleic acids | EPOCH BIOSCIENCES INC. (US) | 2007-07-19 | — | — | US | disclosed |
| US-6951930-B2 | Hybridization-triggered fluorescent detection of nucleic acids | EPOCH BIOSCIENCES, INC. (US) | 2005-10-04 | — | — | US | disclosed |
| US-20030113765-A1 | Hybridization-triggered fluorescent detection of nucleic acids | EPOCH BIOSCIENCES, INC. (US) | 2003-06-19 | — | — | US | disclosed |
| US-6472153-B1 | COVALENTLY BOUND OLIGONUCLEOTIDE/MINOR GROOVE BINDER/LATENT FLUOROPHORE COMBINATION | EPOCH BIOSCIENCES, INC. | 2002-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080075660-A1 | Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications | PHOSPHO1, FABP2, PNLIP | IDO1 2682/4885MEN1 1010/4885KMT2A 4118/4885 |
| US-20070166723-A1 | Hybridization-triggered fluorescent detection of nucleic acids | DDX21, RNGTT, NOP2 | IDO1 4747/4885MEN1 2259/4885KMT2A 3428/4885 |
| US-20030113765-A1 | Hybridization-triggered fluorescent detection of nucleic acids | DDX21, RNGTT, NOP2 | IDO1 4747/4885MEN1 2259/4885KMT2A 3428/4885 |
| US-20100184601-A1 | Method and Means Relating to Multiple Herbicide Resistance in Plants | GSTO1, GSTP1, GSR | IDO1 3045/4885MEN1 4463/4885KMT2A 1267/4885 |
| US-20080262254-A1 | Sphingolipids | SGMS2, SGMS1, SGPL1 | IDO1 1273/4885MEN1 376/4885KMT2A 2656/4885 |
| US-20230173018-A1 | CASPOFUNGIN DERIVATIVES AND ASSAYS FOR EVALUATING ANTIFUNGAL TREATMENT EFFICACY | ERG28, CASP1, CASP7 | IDO1 2705/4885MEN1 1052/4885KMT2A 4452/4885 |
| US-20080014649-A1 | Method for the Determination of Body Odor | OR10J3, OR51E2, DRD4 | IDO1 1396/4885MEN1 1731/4885KMT2A 1503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.